药物对比
Eptinezumab vs Rimegepant
比较 Eptinezumab（Vyepti）和 Rimegepant（Nurtec）两种 CGRP 偏头痛药物。每季度一次静脉输注预防对比口服急性及预防性治疗。
此页面暂无可用的对比维度。
临床背景
Patients with migraine considering CGRP-targeted options compare an IV monoclonal antibody for prevention against an oral gepant usable for both acute attacks and prevention.
结论
The preferred agent depends on whether the priority is infrequent IV prevention or versatile oral acute-plus-preventive therapy.
全部药物对比